Starting with Exelixis’ condition on in-house dispensing data, manufacturers are introducing a new approach to 340B claims focused on transparency.
|Articles|January 26, 2004
NABP proposes wholesaler Rx pedigree to combat counterfeits
Wholesalers would have to create pedigrees for drugs they receive and ship by 2007 under revisions to the model wholesaler licensure rule proposed by the National Association of Boards of Pharmacy.
Advertisement
Advertisement
Related to this article
Advertisement
Advertisement
Trending on Drug Topics
1
FDA Approves Update for Winrevair Based on Phase 3 HYPERION Trial Data
2
GLP-1 Therapy Must Prioritize Metabolic Quality Over Weight Loss
3
PPV23 Vaccination Found to Not Reduce Cardiovascular Risk
4
Q&A: Pharmacist Duties Highlight Need for Provider Status Legislation
5